Pricing Log in Create free account

Castle Biosciences, Inc. (CSTL) vs Freenome, Inc (FRNM)

Castle Biosciences, Inc. and Freenome, Inc are both Diagnostics & Research companies. Castle Biosciences, Inc. and Freenome, Inc are of similar size ($1.1B and $1.0B). Freenome, Inc has the higher net margin (0.00% vs −6.10%) and the higher return on invested capital (0.00% vs −3.63%). Across the 12 metrics below, Freenome, Inc leads on 8 and Castle Biosciences, Inc. on 4.

Valuation

Metric CSTL FRNM Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.77 n/m 4.24
P/B 2.19 n/m 3.42
Price to free cash flow 262.33 n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 2.10 n/m 5.18
Earnings yield (2.25%) (2.98%) (1.50%)
Free cash flow yield 0.38% (3.55%) 0.00%

Profitability

Metric CSTL FRNM Diagnostics & Research median
Gross margin 77.07% — 48.32%
Operating margin (7.43%) 0.00% (5.68%)
Net margin (6.10%) 0.00% (4.10%)
Free cash flow margin 1.06% 0.00% 0.00%
Return on equity (4.87%) 17.81% 0.00%
Return on assets (4.03%) (0.86%) (6.05%)
Return on invested capital (3.63%) 0.00% 0.00%

Growth

Metric CSTL FRNM Diagnostics & Research median
Revenue growth (TTM) 9.78% — 8.99%
EPS growth (last fiscal year) (233.87%) (58.34%) 20.36%
Revenue growth, 5-year CAGR 40.60% — 7.30%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CSTL FRNM Diagnostics & Research median
Debt to equity 0.01 0.00 0.01
Current ratio 5.28 0.20 2.27
Net debt to EBITDA 46.20 0.29 0.68

Dividend

Metric CSTL FRNM Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric CSTL FRNM Diagnostics & Research median
Market cap 1.04b 1.12b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack